Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B
Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phyllanthus Urinaria - Adenosma Glutinosum - Eclipta Prostrata - Ascorbic Acid combination
plus Tenofovir in treatment of acute and chronic hepatitis B. Method the combination of drugs
derived from natural and artificial medicaments.
Has stronger effect on immune system, effective good against HBV replication. This is a
substantial new insight into the pathogenesis of disease, with a clear path toward clinical
application, or which would lead to a substantial advance and perfect in management or public
health policy.